HRTX
NASD Heron Therapeutics Inc$0.4061 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4061, and at the day’s high of $0.4100
- YTD change
- -68.76%
- vs 20-day SMA
- +27.08%
- vs 200-day SMA
- -47.92%
Price ranges
Price & Performance
-0.45 (-52.39%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.1% away from all-time highs of $42.9000
- HRTX is down 69% since the beginning of the year
- HRTX is down 69% over the past 12 months
- HRTX is up 26% over the past 1 month
- 27% of all HRTX investors are betting against HRTX
HRTX reads very good: price sits above one of the two key moving averages, the 12-month move is -68.3%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +14.11%
- vs 8-day SMA
- +17.40%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
